Ogivri 420 mg powder for concentrate for solution for infusion

DRUG2 trials

Sponsors

Fondazione IRCCS Istituto Nazionale Dei Tumori, Istituto Di Candiolo Fondazione Del Piemonte Per L'Oncologia IRCCS

Conditions

Endometrial cancerbreast cancer

Phase 2

Optimization of De-EscalatiON strategies in early breast cancer

Not yet recruitingCTIS2026-527524-27-00

Istituto Di Candiolo Fondazione Del Piemonte Per L'Oncologia IRCCSbreast cancer

Target: 1Updated: 2026-09-14

Phase 4

Akynzeo as antiemetic treatment in patients with endometrial cancer treated with taxane - platinum combination chemotherapy. NOEME study.

RecruitingCTIS2023-504150-35-00

Fondazione IRCCS Istituto Nazionale Dei TumoriEndometrial cancer

Start: 2024-02-21Target: 84Updated: 2025-12-01